Virtu KCG Holdings’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Virtu KCG Holdings’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,839	Closed	-$252K	–	4284
2015 Q3	$252K	Sell	5,839 -4,848	-45%	-$205K	﹤0.01%	2303
2015 Q2	$452K	Buy	+10,687	New	+$451K	0.01%	1590
2014 Q4	–	Sell	-6,857	Closed	-$240K	–	4540
2014 Q3	$240K	Buy	+6,857	New	+$235K	﹤0.01%	2673

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Virtu KCG Holdings's WX Position: Q4 2015 in Review

Virtu KCG Holdings sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 5,839 shares — an estimated $252K sold.

Virtu KCG Holdings first reported a position in WX in Q3 2014 and held it in 3 quarters. The position peaked at $452K in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Virtu KCG Holdings reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Virtu KCG Holdings sold 5,839 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $252K.
Virtu KCG Holdings first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014 and held it in 3 quarters.
Virtu KCG Holdings's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $452K in Q2 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.